Skip to main content
. 2019 Jun 2;2019:7396870. doi: 10.1155/2019/7396870

Table 4.

Liver-related adverse events at the end of observation.

PBC(N=226) PBC/SS(N=56) P value
Death (%) 9(4.0) 2(3.6) 0.877
HCC (%) 2(0.8) 1(1.8) 0.557
Liver transplantation (%) 2(0.8) 0(0) 0.481
Liver-related adverse events (%) 13(5.8) 3(5.4) 1.000

HCC, hepatocellular carcinoma; SS, Sjögren's syndrome; and PBC, primary biliary cholangitis.